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Epidemiology and aetiology of maternal 
parasitic infections in low- and middle-  
income countries
Background There have been very few systematic reviews looking 
at maternal infections in the developing world, even though cut-
ting maternal mortality by three quarters is United Nation’s Mil-
lennium Development Goal number five. This systematic review 
has two aims. The first is to present the prevalence of parasitic in-
fections in the developing world over the last 30 years and the 
second is to evaluate the quality and distribution of research in 
this field.
Methods A systematic review of Medline, EMBASE and Global 
Health databases was undertaken using pre-determined search cri-
teria. Three levels of quality criteria for exclusion of inadequate stud-
ies identified 115 out of initial 8580 titles. The data were extracted 
for 5 domains: worldwide pathogen prevalence, year of study, study 
setting, sample size and diagnostic test for each pathogen.
Results The initial search retrieved 8580 results. From these titles, 
43 studies on malaria, 12 studies on helminths, 49 studies on 
Toxoplasma gondii, 7 studies on Chagas disease, 5 studies on Tricho-
monas, 1 leishmaniasis study and 1 study on trichinellosis were 
extracted for analysis. High prevalence of malaria was found in 
Gabon (up to 57%) India (55%), Cameroon (50%), Yemen (55%), 
Nigeria (up to 64%) and Ghana (54%). High prevalence of hook-
worm infections was found in Nepal at 78.8% and high values of 
Ascaris lumbricoides were found in Nepal, (56.2%), Kenya (52.3%) 
and Gabon (45.5%). High levels of Schistosoma mansoni were 
found in Zimbabwe (50%) and Tanzania (63.5%). The prevalence 
of active Toxoplasma gondii infection was found to be highest in 
India (27.7%).
Conclusion This study highlights the large burden of maternal par-
asitic infections globally. It may serve as a useful starting point for 
health policy development and research prioritization in this area.
With 5 years to go until 2015 and the end of the period to achieve Mil-
lennium Development Goals (MDGs) targets, it is debatable how many of 
the MDGs will reach the aims defined in 2000. MDG 5 aims to: “Reduce 
by three quarters the maternal mortality ratio” (1). However, between 
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1990 and 2005, in Sub-Saharan Africa especially, little 
progress had been made and in some countries the figures 
have even increased (1). In 1990, the Democratic Republic 
of Congo had a maternal mortality ratio (MMR) of 870 per 
100 000 and by 2005 it had increased to 1100 per 100 000 
(1). In addition, in Tanzania, which is a more stable sub-
Saharan African country, the MMR also increased from 770 
per 100 000 in 1990 to 970 per 100 000 (1). At the recent 
review of the MDGs in 2010, the UN managed to secure 
US$ 40 billion (€ 30 billion) for women’s and children’s 
health alone (2). 
Maternal deaths are due to many causes including haem-
orrhage, hypertensive disorders, abortion related compli-
cations, infections and sepsis (3). Maternal infections con-
tribute to about 10–20% of these deaths (3). It is therefore 
imperative that there is up to date research on these topics. 
So far, there have been no systematic reviews of the data. 
This review aims to summarise the research that has been 
undertaken in the past 30 years. It will look at the global 
distribution of research and the year in which the research 
was done. It will also look at how this research was under-
taken, where the research was done, how many subjects 
were included in papers and what microbiological diagnos-
tic methods were used. Finally the paper will set out an 
up-to-date picture of the prevalence of parasitic infections 
in the developing world over the last 30 years. 
METHODS
Literature search terms
Initial searches were conducted to identify suitable keywords 
and MeSH headings to use in the final search (Table 1). The 
search strategy was prepared with an input from a librarian. 
Searches were conducted in parallel by two reviewers (us-
ing OVID) in the following databases on 1 August 2010: 
Medline (1950 to August Week 4 2010); EMBASE (1980 
to 2010 Week 30) and Global Health (1973 to August 
2010).
Study inclusion and exclusion criteria
Studies were screened by title and then by abstract for rel-
evance. Studies were deemed relevant if they provided in-
formation on the aetiology or epidemiology of parasitic in-
fections in pregnant women in developing countries. These 
studies were then grouped according to pathogen studied, 
with some studies providing information on multiple 
pathogens. Studies providing information on the epidemi-
ology of bacterial or viral infections in pregnant women 
were identified but not analyzed, as they were addressed 
in a separate review. Relevant English language papers were 
analyzed in this work, along with Chinese electronic data-
bases, with the intention of translating and analyzing non-
English papers, too. The inclusion criteria were:
Subjects: Pregnant women at any stage of pregnancy or la-
bour, including the puerperium (up to 42 days after la-
bour);
Study location: Low- and middle-income countries (as de-
fined by the World Bank in 2010);
Study design and sampling methods: No restrictions ap-
plied;
Data collection: Only studies that provided evidence of 
parasitic infection using microbiological or serological test 
results were included;
Results: Papers were selected if they provided information 
on the burden of a particular pathogen (the prevalence of 
a particular infection in pregnant women in the commu-
nity over time/incidence) and/or the aetiology of parasitical 
maternal infections (prevalence of a specific pathogen/in-
fection).
Table 1 Search terms used to identify published articles on the 
prevalence and aetiology of maternal infections in the develop-
ing world
exp Infection/
AND
exp Pregnancy/ OR exp Pregnancy Complications, Infectious/
AND
exp Developing Countries OR africa/ or africa, northern/ or algeria/ or egypt/ 
or libya/ or morocco/ or tunisia/ or “africa south of the sahara”/ or africa, cen-
tral/ or cameroon/ or central african republic/ or chad/ or congo/ or “demo-
cratic republic of the congo”/ or gabon/ or africa, eastern/ or burundi/ or dji-
bouti/ or eritrea/ or ethiopia/ or kenya/ or rwanda/ or somalia/ or sudan/ or 
tanzania/ or uganda/ or africa, southern/ or angola/ or botswana/ or lesotho/ 
or malawi/ or mozambique/ or namibia/ or south africa/ or swaziland/ or zam-
bia/ or zimbabwe/ or africa, western/ or benin/ or burkina faso/ or cape verde/ 
or cote d’ivoire/ or gambia/ or ghana/ or guinea/ or guinea-bissau/ or liberia/ 
or mali/ or mauritania/ or niger/ or nigeria/ or senegal/ or sierra leone/ or togo/ 
or caribbean region/ or west indies/ or “antigua and barbuda”/ or cuba/ or 
dominica/ or dominican republic/ or grenada/ or guadeloupe/ or haiti/ or ja-
maica/ or martinique/ or “saint kitts and nevis”/ or saint lucia/ or “saint vin-
cent and the grenadines”/ or central america/ or belize/ or costa rica/ or el sal-
vador/ or guatemala/ or honduras/ or nicaragua/ or panama/ or latin america/ 
or mexico/ or south america/ or argentina/ or bolivia/ or brazil/ or chile/ or 
colombia/ or ecuador/ or french guiana/ or guyana/ or paraguay/ or peru/ or 
suriname/ or uruguay/ or venezuela/ or asia/ or asia, central/ or kazakhstan/ 
or kyrgyzstan/ or tajikistan/ or turkmenistan/ or uzbekistan/ or asia, south-
eastern/ or borneo/ or brunei/ or cambodia/ or east timor/ or indonesia/ or laos/ 
or malaysia/ or mekong valley/ or myanmar/ or philippines/ or thailand/ or 
vietnam/ or asia, western/ or bangladesh/ or bhutan/ or india/ or sikkim/ or 
middle east/ or afghanistan/ or iran/ or iraq/ or jordan/ or lebanon/ or syria/ or 
turkey/ or yemen/ or nepal/ or pakistan/ or sri lanka/ or far east/ or china/ or 
tibet/ or “democratic people’s republic of korea”/ or mongolia/ or taiwan/ or 
atlantic islands/ or azores/ or albania/ or lithuania/ or bosnia-herzegovina / or 
bulgaria/ or byelarus/ or “macedonia (republic)”/ or moldova/ or montenegro/ 
or romania/ or russia/ or bashkiria/ or dagestan/ or moscow/ or siberia/ or ser-
bia/ or ukraine/ or yugoslavia/ or armenia/ or azerbaijan/ or “georgia (repub-
lic)”/ or indian ocean islands/ or comoros/ or madagascar/ or mauritius/ or re-
union/ or seychelles/ or fiji/ or papua new guinea/ or vanuatu/ or guam/ or 
palau/ or “independent state of samoa”/ or tonga/
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Quality criteria
Papers were required to describe their samples and meth-
ods in detail, and provide microbiological or serological 
evidence of the aetiology of infection.
Data extraction
Information on pathogen studied, sample population 
(pregnant women studied during pregnancy or at labour) 
and size, study setting, duration and type, microbiological/
serological test used and results were extracted from ab-
stracts and full papers for analysis.
Data analysis
Epidemiology and aetiology of maternal parasitic infections 
were summarized according to the pathogen studied. On-
ly pathogens with 5 or more studies reporting on its epi-
demiology and/or aetiology were analyzed. Median preva-
lence of each infection was calculated and trends in the 
prevalence of maternal infections were noted.
Selection of studies
The final search yielded 8580 relevant titles. Figure 1 out-
lines the results of the search process and application of 
inclusion and exclusion criteria, resulting in the final pan-
el of studies from which data was extracted.
Studies retained for data extraction (n=115) characterized 
the prevalence of 6 parasitic pathogens (malaria, helminths, 
Toxoplasma gondii, Chagas disease, trichinellosis and Tricho-
monas vaginalis) among pregnant women in developing 
countries, with 3 further reports providing secondary 
cross-sectional insights or reviews of the literature in this 
field, which were considered useful (4–118).
RESULTS
Prevalence of parasitical infections
Malaria. We identified 43 studies characterizing the prev-
alence of maternal malaria in 19 developing countries (Sup-
plementary Table 1). The features and results of these stud-
ies are summarised in Table 2 and Figures 2 to 4.
The majority of studies had small sample sizes (Table 2), 
between 0–500 subjects and most of them were conducted 
in antenatal clinics or hospitals (82.7%), suggesting either 
awareness towards the need for antenatal screening for ma-
ternal malaria infection, or merely that it is much easier to 
recruit study subjects in health care facilities. The remain-
ing studies (8.9%) were community-based and the study 
setting was not specified in 8.4%.
Blood smears with Giemsa stains were by far the most reg-
ularly used diagnostic test, accounting for 47% of all tests 
Figure 1 Summary of the literature search conducted.
Search retrieved
8580 titles
Titles screened for relevance
1450 titles retained
558 studies with information on parasitical infections  
in pregnant women identified
115 studies retained for data extraction; sorted according to pathogen  
studied (a pathogen was only studied if there were 5 or more papers  
reporting the epidemiology of the pathogen)
Abstracts available screened 
for relevance
Quality criteria applied
Table 2 Distribution according to the size of population studied 
in 43 studies reporting maternal malaria prevalence
Size of population Number (%)
0–500  28 (65%)
501–1000    6 (14%)
1001–1500 4 (9%)
1501–2000 0 (0%)
2001–2500 0 (0%)
2501–3000 1 (2%)
3001–3500 0 (0%)
3501–4000 1 (2%)
4001–4500 1 (2%)
4501–5000 0 (0%)
>5000 2 (5%)
Figure 2 Geographical distribution of studies (n=43) reporting 
the prevalence of maternal malaria. “No data” in the legend 
refers to low- and middle-income countries only, as data from 
high-income countries were not the subject of this study.
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used to detect Malaria (Figure 3). Very high prevalence, of 
Plasmodium vivax (78.69%) was found in Brazil (28). Nine 
studies in seven different countries reported prevalence of 
over 50%: Gabon (57% and 54%) India (55%), Cameroon 
(50%), Yemen (55%), Nigeria (57% and 64%) and Ghana 
(54%) (26,29,39,46,47,49,51). The mean prevalence of 
malaria, regardless of the blood site taken from, was be-
tween 20–30%, suggesting a degree of consistency between 
tests from different blood sites (Figure 4). 
Helminths. Fourteen studies characterizing the prevalence 
of maternal infections with helminths in 11 developing 
countries were identified (Supplementary Table 2). The 
features and results of these studies are summarised in Ta-
ble 3 and Figures 5 to 7.
The majority of studies had small sample sizes (Table 3), 
between 0–500 subjects and most of them were conducted 
in antenatal clinics or hospitals (75%), suggesting either 
awareness towards the need for antenatal screening for ma-
ternal malaria infection, or merely that it is much easier to 
recruit study subjects in health care facilities. The remain-
ing studies (18%) were community-based and the study 
setting was not specified in 9%.
Between the studies there was a generalised trend to use 
the Kato-Katz technique for examining stool samples (Fig-
ure 6), which is the gold standard for an epidemiological 
survey of helminth eggs (119). The prevalence of the dif-
ferent helminths varied across the studies. The most prev-
alent was hookworm, with a mean prevalence of 45%. The 
highest prevalence of hookworm infections was found in 
Nepal at 78.8% and high values were found in Uganda 
(44.5% and 45% in 2 studies), Tanzania  (56.3%) and Ke-
nya (39.5%) (12,16,18,19,24). For Ascaris lumbricoides rel-
atively high prevalences were found in Nepal, (56.2%), 
Kenya (52.3%) and Gabon (45.5%) (11,18,19). Trichuris 
trichiura was least prevalent with a highest prevalence of 
31% in Gabon and a mean value of 13% (11). High levels 
of Schistosoma mansoni were found in Zimbabwe (50%) and 
Tanzania (63.5%), but the prevalence in other countries 
was typically around 30% (10,24) (Figure 7).
Toxoplasma gondii. Forty-nine studies characterizing the 
prevalence of maternal infections with T. gondii in 26 de-
veloping countries were identified (Supplementary Table 
3). The features and results of these studies are summarised 
in Table 4 and Figures 8 to 10.
The majority of studies had small sample sizes (Table 4), 
between 0–500 subjects. Twenty five percent of the studies 
Figure 3 Techniques used to diagnose maternal malaria in the 
43 studies identified. PCR – polymerase chain reaction, HRP2 
test – histidine-rich protein 2.
Figure 4 Box plot of malaria prevalence in different blood 
samples, reported by 43 relevant studies. The following 
number summaries are depicted in the box plot: sample 
minimum, lower quartile, median, upper quartile, and sample 
maximum.
Table 3 Distribution according to size of population studied in 
14 studies reporting maternal infection with helminth preva-
lence
Size of population Number (%)
0–500 9 (69%)
501–1000 0 (0%)
1001–1500 1 (8%)
1501–2000 0 (0%)
2001–2500 1 (8%)
2501–3000 2 (15%)
3001–3500 0 (0%)
3501–4000 0 (0%)
4001–4500 0 (0%)
4501–5000 0 (0%)
>5000 0 (0%)
Figure 5 Geographical distribution of studies (n=14) reporting the 
prevalence of maternal infection with helminths. “No data” in the 
legend refers to low- and middle-income countries only, as data 
from high-income countries were not the subject of this study.
Tom Roberts et al.
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were conducted in antenatal clinics, hospitals, health care 
facilities or prenatal clinics. The remaining studies (2%) 
were community-based and the study setting was not spec-
ified in 75% of the studies.
The most commonly used test was ELISA, which is the gold 
standard for T. gondii analysis (Figure 9). The prevalence 
of both IgG and IgM was measured in 22 out of the 49 
studies, useful for analysing current (IgM) and past (IgG) 
infections in pregnant mothers. The prevalence of active 
infection was low with a mean of 4% but there were high 
levels in India (27.7%), Mexico (20.7%) and Sudan 
(14.3%). The mean IgG (past infection) prevalence was 
39%, highest prevalence in Brazil (75.1%) (Figure 10). 
Chagas disease. Seven characterizing the prevalence of 
maternal infections with Chagas disease in 7 developing 
countries were identified (Supplementary Table 4). The 
features and results of these studies are summarised in Ta-
ble 5 and Figures 11 to 13.
The majority of studies had small sample sizes (Table 5), 
between 0–500 subjects. Fourteen percent of the studies 
were conducted in hospitals, 29% in endemic and 29% in 
non-endemic areas. The remaining studies (14%) were 
conducted in parturient and the study setting was not spec-
ified in 14% of the studies.
The most commonly used tests were indirect immuno-
flouresence and indirect haemogluttination tests (Figure 
12). Chagas disease had a low mean prevalence of around 
7.2% in pregnant women but a study in Bolivia (9) report-
ed a prevalence of 26.3% (Figure 13).
Figure 6 Techniques used to diagnose maternal infection with 
helminths in 14 studies identified.
Figure 7 Box plot of the prevalence of maternal infections with 
helminths reported by the 14 relevant studies. The following 
number summaries are depicted in the box plot: sample 
minimum, lower quartile, median, upper quartile, and sample 
maximum.
Table 4 Distribution according to size of population studied in 
48 studies reporting maternal infection with Toxoplasma gondii 
prevalence
Size of population Number (%)
0–500 29 (60%)
501–1000 6 (13%)
1001–1500 4 (8%)
1501–2000 1 (2%)
2001–2500 2 (4%)
2501–3000 0 (0%)
3001–3500 0 (0%)
3501–4000 0 (0%)
4001–4500 1 (2%)
4501–5000 1 (2%)
>5000 4 (8% )
Figure 8 Geographical distribution of studies (n=49) reporting 
the prevalence of maternal infection with Toxoplasma gondii. 
“No data” in the legend refers to low- and middle-income 
countries only, as data from high-income countries were not the 
subject of this study.
Figure 9 Techniques used to diagnose maternal infection with 
Toxoplasma gondii in 49 studies identified.
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Trichinellosis. There was only one study looking at trich-
inellosis (Supplementary Table 5). Because of the scar-
city of studies it is hard to make any inference to trends, so 
more research needs to be done in this area.
Trichomonas vaginalis. We found only four studies fo-
cused on trichomoniasis (Supplementary Table 6). Be-
cause of the scarcity of studies it is hard to make any infer-
ence to trends and more research is needed.
DISCUSSION
Prevalence of parasitic infections
Our search of published literature relevant to the aetiology 
and epidemiology of maternal parasitic infections in the 
developing world provided detailed epidemiological infor-
mation on 6 maternal infections. These 6 parasitical mater-
nal infections were most extensively studied, suggesting 
that these infections have a high burden on pregnancy out-
comes in the developing world. These infections also have 
potential adverse effects on neonates.
Malaria in its own right is a major contributing factor to-
wards maternal deaths worldwide. It causes severe anaemia 
and can affect newborn’s birth-weight and long-term sur-
vival (119). For this reason, it is recommended that re-
search conducted in South and Central America, especial-
ly Brazil where the prevalence of P. vivax was so high 
(78.69%) to be expanded (28).  Further research should 
also be concentrated on regions classified as high risk but 
with a current lack of data like Democratic Republic of 
Congo, Angola and Zambia, from where no evidence of re-
search was found. Finally, prevention strategies should be 
encouraged in the maternal populations from the countries 
with evidence of very high malaria prevalence, namely Ga-
bon, India, Cameroon, Yemen, Nigeria and Ghana (26,29, 
39,46,47,49,51).
Figure 10 Box plot of maternal infections with Toxoplasma 
gondii prevalence reported by 48 relevant studies. The following 
number summaries are depicted in the box plot: sample 
minimum, lower quartile, median, upper quartile, and sample 
maximum. Asterisks indicate outliers.
Figure 11 Geographical distribution of studies (n=7) reporting 
the prevalence of maternal infection with Chagas disease. “No 
data” in the legend refers to low- and middle-income countries 
only, as data from high-income countries were not the subject 
of this study.
Figure 12 Techniques used to diagnose maternal infection with 
Toxoplasma gondii in the 49 studies identified.
Figure 13 Box plot of maternal infections with Chagas disase 
prevalence reported by the 749 relevant studies. The following 
number summaries are depicted in the box plot: sample 
minimum, lower quartile, median, upper quartile, sample 
maximum. Asterisk indicates an outlier.
Table 5 Distribution according to size of population studied in 7 
studies reporting maternal infection with Chagas disease 
prevalence
Size of population Number (%)
0–500 1 (14%)
501–1000 2 (29%)
1001–1500 0 (0%)
1501–2000 0 (0%)
2001–2500 3 (43%)
2501–3000 0 (0%)
3001–3500 1 (14%)
3501–4000 0 (0%)
4001–4500 0 (0%)
4501–5000 0 (0%)
>5000 0 (0%)
Tom Roberts et al.
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Hookworm infections were found to be well studied, which 
is very promising as these parasites cause anaemia during 
pregnancy and have been noted to increase the maternal 
and child mortality rates (120). However more studies 
looking at Schistosoma would definitely be recommended 
as there were only 4 studies in pregnant women, despite 
WHO’s statement that Schistosoma is “second only to ma-
laria in public health importance” and pregnant women are 
one of the important at risk groups (121). Specific coun-
tries of note for further investigation and preventative mea-
sures would be Nepal for hookworms (78.8%) and A. lum-
bricoides (56.2%) (19); Tanzania for hookworms (56.3%) 
and Schistosoma mansoni (63.5%) (24); Kenya for hook-
worms (39.5%) and A. lumbricoides (52.3%); the Gabon for 
A. lumbricoides (45.5%) and Trichuris trichuria (31%); and 
finally for S. mansoni (50%) (10,11,18).
Chagas disease is important because of its potential to cause 
mortality in all age-groups. It can be transmitted vertically 
so that the knowledge of maternal prevalence is important 
(122). Although this review has shown studies in South 
America, the disease is no longer confined to just South 
America, as with Latino American emigration there has 
been a movement of the disease across the world. There-
fore global research in areas of high Latino American im-
migration would be recommended to assess the extent this 
emigration has had (123). More funding in Bolivia would 
be recommended to assess the nature of the 26.3% preva-
lence of maternal infection and its effects on maternal and 
neonatal health (9).
There is a need for more  studies on Leishmania. Although 
not much evidence can be taken from the single study from 
Brazil (124), pregnant woman tended to have more severe 
Leishmania than the non-pregnant infected subjects and 
there was a possible link with increased problems with 
pregnancy.
Strengths and limitations
To our knowledge, this is the first review that summarises 
the epidemiology of maternal parasitic infections in the de-
veloping world. The search strategy devised was sensitive 
and specific, which allowed for a comprehensive review of 
available literature on this topic. The information gener-
ated in this review can be used to guide public health pol-
icy and the allocation of resources within local govern-
ments and by the international community towards 
improving maternal health.  Although the search did not 
exclude non-English papers, we did not search some of the 
databases where we would have expected a higher concen-
tration of foreign language papers (e.g. LILACS). Although 
the databases used were very extensive, especially in the 
case of EMBASE and Medline there is a high chance that 
important papers could have been recovered from smaller, 
more specialist databases.
This study could be further improved by analysing non-
English studies conducted in francophone parts of Africa 
(in French), South America (in Spanish) and in China (in 
Chinese), which could be accessed from appropriate data-
bases. Reviewing non-English articles may assist in defin-
ing the epidemiology of pathogens for which we managed 
to identify few (<5) studies, as well as providing more ro-
bust data on the pathogens presented in this review. In ad-
dition, searching grey (unpublished) literature or contact-
ing health officials and researchers in the field may also 
yield more country specific data on the subject, thus en-
abling more targeted and context-specific public health 
measures. 
Recommendations and future work
This systematic review highlights the quantity of maternal 
parasitic infection research and, to a lesser extent, quality 
of research that has been achieved over the last 30 years. 
This paper would therefore be useful to decision makers, 
especially in light of the US$ 40 billion (€ 30 billion) 
pledged at the last UN’s MDG summit, to help them assess 
where best to implement resources for research. It could 
also be a useful tool to measure how good the data is for 
each individual parasite and in assessing what areas of the 
world have been neglected in terms of research. With a full 
picture where different maternal infections occur, it could 
be used as a tool to target research and could ultimately 
lead to big leap forward maternal infections knowledge, 
therefore helping in the fight towards cutting down mater-
nal infections.
Conclusion
No mother should die during childbirth and every step 
should be taken to stop this happening. This review is a 
first step, in a long chain of events, trying to prevent ma-
ternal mortality. If research and knowledge is channelled 
into the right areas and decision makers have accurate 
knowledge regarding maternal infections then resources 
can be allocated to those areas that need it most. 
Researchers have a responsibility to reflect on which part 
of the world current knowledge is stemming from and 
should look retrospectively to see how much research has 
been done in the past. By doing this, the public health com-
munity can positively expand research into areas of the 
world and into diseases where that information is lacking. 
And with this information, informed and important deci-
sion can be made about the factors that affect maternal 
mortality most and maybe, just maybe, Millennium Devel-
opment Goal 5 can be achieved.
Epidemiology and aetiology of maternal parasitic infections in low and middle income countries
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